The DOI matches its Crossref record; 324 of the 324 references it cites were found in a registry or an index.
Cancer Cell Signaling Pathways Targeted by Spice-Derived Nutraceuticals
Open accessAbstract
Extensive research within the last half a century has revealed that cancer is caused by dysregulation of as many as 500 different gene products. Most natural products target multiple gene products and thus are ideally suited for prevention and treatment of various chronic diseases, including cancer. Dietary agents such as spices have been used extensively in the Eastern world for a variety of ailments for millennia, and five centuries ago they took a golden journey to the Western world. Various spice-derived nutraceuticals, including 1'-acetoxychavicol acetate, anethole, capsaicin, cardamonin, curcumin, dibenzoylmethane, diosgenin, eugenol, gambogic acid, gingerol, thymoquinone, ursolic acid, xanthohumol, and zerumbone derived from galangal, anise, red chili, black cardamom, turmeric, licorice, fenugreek, clove, kokum, ginger, black cumin, rosemary, hop, and pinecone ginger, respectively, are the focus of this review. The modulation of various transcription factors, growth factors, protein kinases, and inflammatory mediators by these spice-derived nutraceuticals are described. The anticancer potential through the modulation of various targets is also the subject of this review. Although they have always been used to improve taste and color and as a preservative, they are now also used for prevention and treatment of a wide variety of chronic inflammatory diseases, including cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Eugenol inhibits tumor proliferation and formation, increases reactive oxygen species (ROS), generates apoptosis, and has a genotoxic effect in different cancer cells [23,29,30,31].”
From Clove essential oil (Syzygium aromaticum L. Myrtaceae): Extraction, chemical composition, food applications, and essential bioactivity for human health (2021) · cites this paper as [29]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Tekeoğlu, İ., Doğan, A., & Demiralp, L. (2006) · Phytotherapy Research · doi:10.1002/ptr.1964 · Cited by 47
RetractedChromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
Marmot, M. G., Atinmo, T., Byers, T., Chen, J., Hirohata, T., Jackson, A., James, W., Kolonel, L. N., Kumanyika, S., Leitzmann, C., et al. (2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,368
Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
Mutations affecting segment number and polarity in Drosophila
Nüsslein‐Volhard, C., & Wieschaus, E. F. (1980) · Nature · doi:10.1038/287795a0 · Cited by 4,370
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
Cell Signaling by Receptor Tyrosine Kinases
Schlessinger, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00114-8 · Cited by 3,774
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A. F., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,448
Hedgehog signaling in animal development: paradigms and principlesPreprint
Ingham, P. W., & McMahon, A. P. (2001) · Genes & Development · doi:10.1101/gad.938601 · Cited by 3,025
AP-1 as a regulator of cell life and death
Shaulian, E., & Karin, M. (2002) · Nature Cell Biology · doi:10.1038/ncb0502-e131 · Cited by 2,961 · cited 1×
“Numerous data suggest that the activation of AP-1 plays a major role in proliferation and metastasis of tumor cells ( 62 , 63 ).”
BackgroundCancer chemoprevention with dietary phytochemicals
Surh, Y.-J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1189 · Cited by 2,955
Carpenter, G., & Cohen, S. (1979) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.48.070179.001205 · Cited by 2,936
Signalling pathways of the TNF superfamily: a double-edged sword
Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793
Self-citationCancer is a preventable disease that requires major lifestyle changes
Anand, P., Kunnumakara, A. B., Sundaram, C., Harikumar, K. B., Tharakan, S. T., Lai, O. S., Sung, B., & Aggarwal, B. B. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9661-9 · Cited by 2,632
Self-citationGenomic DNA methylation: the mark and its mediators.
Klose, R. J., & Bird, A. P. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.12.008 · Cited by 2,501
Cyclin is degraded by the ubiquitin pathway
Glotzer, M., Murray, A. W., & Kirschner, M. W. (1991) · Nature · doi:10.1038/349132a0 · Cited by 2,359
Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer
Rikova, K., Guo, A., Zeng, Q., Possemato, A., Yu, J., Haack, H., Nardone, J., Lee, K., Reeves, C., Li, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.11.025 · Cited by 2,317
Wnt proteins are lipid-modified and can act as stem cell growth factors
Willert, K., Brown, J. D., Danenberg, E., Duncan, A. W., Weissman, I. L., Reya, T., Yates, J. R., & Nusse, R. (2003) · Nature · doi:10.1038/nature01611 · Cited by 2,257
AP-1: a double-edged sword in tumorigenesis
Eferl, R., & Wagner, E. F. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1209 · Cited by 2,218
Cancer epigenomics: DNA methylomes and histone-modification maps
Esteller, M. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2005 · Cited by 2,190
Cheng, A., Hsu, C., Lin, J., Hsu, M. M., Ho, Y., Shen, T. S., Ko, J. Y., Lin, J.-T., Lin, B., Ming-Shiang, W., et al. (2001) · PubMed · Cited by 2,071
Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070
Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90807-x · Cited by 1,961
Nusse, R., & VARMUS, H. E. (1982) · Cell · doi:10.1016/0092-8674(82)90409-3 · Cited by 1,864
Pagano, M., Tam, S. W., Theodoras, A. M., Beer‐Romero, P., Sal, G. D., Chau, V., Yew, P. R., Draetta, G. F., & Rolfe, M. (1995) · Science · doi:10.1126/science.7624798 · Cited by 1,815
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
AP-1 in cell proliferation and survival
Shaulian, E., & Karin, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204383 · Cited by 1,733
Sugarman, B. J., Aggarwal, B. B., Hass, P. E., Figari, I. S., Palladino, M. A., & Shepard, H. M. (1985) · Science · doi:10.1126/science.3933111 · Cited by 1,572
Self-citationSynthesis and Function of 3-Phosphorylated Inositol Lipids
Vanhaesebroeck, B., Leevers, S. J., Ahmadi, K., Timms, J., Katso, R., Driscoll, P. C., Woscholski, R., Parker, P. J., & Waterfield, M. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.535 · Cited by 1,535
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D. S., Armellino, D. C., Gospodarowicz, D., & Böhlen, P. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90483-2 · Cited by 1,519
Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)
Singh, S., & Aggarwal, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24995 · Cited by 1,399
Self-citationAutocrine Secretion and Malignant Transformation of Cells
Sporn, M. B., & Todaro, G. J. (1980) · New England Journal of Medicine · doi:10.1056/nejm198010093031511 · Cited by 1,363
Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
Dhillon, N., Aggarwal, B. B., Newman, R. A., Wolff, R. A., Kunnumakkara, A. B., Abbruzzese, J. L., Ng, C. S., Badmaev, V., & Kurzrock, R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0024 · Cited by 1,357
Self-citationChen, Z., Hagler, J., Palombella, V. J., Melandri, F. D., Scherer, D. C., Ballard, D. W., & Maniatis, T. (1995) · Genes & Development · doi:10.1101/gad.9.13.1586 · Cited by 1,270
Phase I Clinical Trial of Oral Curcumin
Sharma, R. A., Euden, S. A., Platton, S. L., Cooke, D. N., Shafayat, A., Hewitt, H. R., Marczylo, T. H., Morgan, B., Hemingway, D., Plummer, S. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0744 · Cited by 1,260
The RAF proteins take centre stage
Wellbrock, C., Karasarides, M., & Marais, R. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1498 · Cited by 1,223
Tissue repair and stem cell renewal in carcinogenesis
Beachy, P. A., Karhadkar, S. S., & Berman, D. M. (2004) · Nature · doi:10.1038/nature03100 · Cited by 1,210
PIK3CA is implicated as an oncogene in ovarian cancer
Shayesteh, L., Lu, Y., Kuo, W.-L., Baldocchi, R. A., Godfrey, T. E., Collins, C. C., Pinkel, D., Powell, B., Mills, G. B., & Gray, J. W. (1999) · Nature Genetics · doi:10.1038/5042 · Cited by 1,158
Ma, J., Pollak, M., Giovannucci, E. L., Chan, J. M., Tao, Y., Hennekens, C. H., & Stampfer, M. J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.7.620 · Cited by 1,118
Ramos-Gomez, M., Kwak, M.-K., Dolan, P. M., Itoh, K., Yamamoto, M., Talalay, P., & Kensler, T. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051618798 · Cited by 1,102
Kunnumakkara, A. B., Anand, P., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.009 · Cited by 1,083
Self-citationHedgehog Signaling in Development and Cancer
Jiang, J., & Hui, C. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.11.010 · Cited by 1,073
Buettner, R., Mora, L. B., & Jove, R. (2002) · PubMed · Cited by 1,036
Akira, S., Nishio, Y., Inoue, M., Wang, X.-J., We, S., Matsusaka, T., Yoshida, K., Sudo, T., Naruto, M., & Kishimoto, T. (1994) · Cell · doi:10.1016/0092-8674(94)90235-6 · Cited by 1,019
Current development of mTOR inhibitors as anticancer agents
Faivre, S. J., Kroemer, G., & Raymond, É. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2062 · Cited by 1,012
Bollrath, J., Phesse, T. J., von Burstin, V. A., Putoczki, T., Bennecke, M., Bateman, T., Nebelsiek, T., Lundgren-May, T., Canli, Ö., Schwitalla, S., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.002 · Cited by 946
NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
Hayes, J. D., & McMahon, M. J. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.12.008 · Cited by 870
Balasubramanyam, K., Varier, R. A., Altaf, M., Venkatesh, S., Siddappa, N. B., Ranga, U., & Kundu, T. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409024200 · Cited by 841
Sharma, R. A., McLelland, H. R., Hill, K. A., Ireson, C. R., Euden, S. A., Manson, M. M., Pirmohamed, M., Marnett, L. J., Gescher, A. J., & Steward, W. P. (2001) · PubMed · Cited by 827
Wakao, H., Gouilleux, F., & Groner, B. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06495.x · Cited by 825
Aggarwal, B. B., Vijayalekshmi, R. V., & Sung, B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0149 · Cited by 812
Self-citationPAX8-PPAR γ 1 Fusion in Oncogene Human Thyroid Carcinoma
Kroll, T. G., Sarraf, P., Pecciarini, L., Chen, C., Mueller, E., Spiegelman, B. M., & Fletcher, J. A. (2000) · Science · doi:10.1126/science.289.5483.1357 · Cited by 780
The development of proteasome inhibitors as anticancer drugs
Adams, J. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00120-5 · Cited by 778
Molina, M. A., Codony‐Servat, J., Albanell, J., Rojo, F., Arribas, J., & Baselga, J. M. (2001) · PubMed · Cited by 766
Isolation and structure of urogastrone and its relationship to epidermal growth factor
Gregory, H. (1975) · Nature · doi:10.1038/257325a0 · Cited by 757
Shibata, T., Ohta, T., Tong, K. I., Kokubu, A., Odogawa, R., Tsuta, K., Asamura, H., Yamamoto, M., & Hirohashi, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806268105 · Cited by 728
Expression of cyclooxygenase-2 in human lung carcinoma.
Wolff, H. J., Saukkonen, K., Anttila, S. L., Karjalainen, A., Vainio, H., & Ristimaki, A. P. (1998) · PubMed · Cited by 722
Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer
Aggarwal, B. B., Kunnumakkara, A. B., Harikumar, K. B., Gupta, S. R., Tharakan, S. T., Koca, C., Dey, S., & Sung, B. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04911.x · Cited by 663
Self-citationKwak, M.-K., Wakabayashi, N., Itoh, K., Motohashi, H., Yamamoto, M. P., & Kensler, T. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211898200 · Cited by 661
PDGF-C is a new protease-activated ligand for the PDGF α-receptor
Li, X., Pontén, A., Aase, K., Karlsson, L. K., Abramsson, A., Uutela, M., Bäckström, G., Hellström, M., Boström, H., Li, H., et al. (2000) · Nature Cell Biology · doi:10.1038/35010579 · Cited by 624
Carling, D., Zammit, V. A., & Hardie, D. G. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80292-2 · Cited by 599
Ireson, C. R., Orr, S., Jones, D. J. L., Verschoyle, R. D., Lim, C. K., Luo, J., Howells, L. M., Plummer, S. M., Jukes, R., Williams, M. L., et al. (2001) · PubMed · Cited by 588
The proteasome: structure, function, and role in the cell
Adams, J. N. (2003) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(03)00081-1 · Cited by 583
Huang, M., Lysz, T. W., Ferraro, T., Abidi, T. F., Laskin, D. L., & Conney, A. H. (1991) · PubMed · Cited by 571
W. H. Fox Talbot and the history of photography
Gernsheim, H. (1977) · Endeavour · doi:10.1016/0160-9327(77)90005-9 · Cited by 566
Plasma Levels of Insulin-Like Growth Factor-I and Lung Cancer Risk: a Case-Control Analysis
Yu, H., Spitz, M. R., Mistry, J., Gu, J., Hong, W. K., & Wu, X. Y. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.2.151 · Cited by 554
A case-control study of gastric cancer and diet in Italy
Buiatti, E., Palli, D., Decarli, A., Amadori, D., Avellini, C., Bianchi, S., Biserni, R., Cipriani, F., Cocco, P., Giacosa, A., et al. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910440409 · Cited by 547
Aggarwal, S., Ichikawa, H., Takada, Y., Sandur, S. K., Shishodia, S., & Aggarwal, B. B. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.017400 · Cited by 532
Self-citationThe ins and outs of Raf kinases
Daum, G., Eisenmann-Tappe, I., Fries, H.-W., Troppmair, J., & Rapp, U. R. (1994) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(94)90133-3 · Cited by 523
Aoki, H., Takada, Y., Kondo, S., Sawaya, R. A., Aggarwal, B. B., & Kondo, Y. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.033167 · Cited by 523
Self-citationTumor necrosis factor or tumor promoting factor?
Balkwill, F. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00020-x · Cited by 520
Bharti, A. C., Donato, N. J., & Aggarwal, B. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3863 · Cited by 511
Self-citationTargeting breast stem cells with the cancer preventive compounds curcumin and piperine
Kakarala, M., Brenner, D. E., Körkaya, H., Cheng, C., Tazi, K., Ginestier, C., Liu, S., Dontu, G., & Wicha, M. S. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0612-x · Cited by 510
Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer
Sarraf, P., Mueller, E., Smith, W. M., Wright, H. M., Kum, J. B., Aaltonen, L. A., de la Chapelle, A., Spiegelman, B. M., & Eng, C. (1999) · Molecular Cell · doi:10.1016/s1097-2765(01)80012-5 · Cited by 508
Garcea, G., Berry, D. P., Jones, D. J. L., Singh, R. K., Dennison, A. R., Farmer, P. B., Sharma, R. A., Steward, W. P., & Gescher, A. J. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.120.14.1 · Cited by 497
The role of herbs and spices in cancer prevention
Kaefer, C., & Milner, J. A. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.11.003 · Cited by 496
The Role of Cyclooxygenase-2 in Cell Proliferation and Cell Death in Human Malignancies
Sobolewski, C., Cerella, C., Dicato, M. A., Ghibelli, L., & Diederich, M. F. (2010) · International Journal of Cell Biology · doi:10.1155/2010/215158 · Cited by 493
Epigenetics in cancer: Targeting chromatin modifications
Ellis, L., Atadja, P. W., & Johnstone, R. W. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0860 · Cited by 488
NF-κB addiction and its role in cancer: ‘one size does not fit all’
Chaturvedi, M., Sung, B., Yadav, V. R., Kannappan, R., & Aggarwal, B. B. (2010) · Oncogene · doi:10.1038/onc.2010.566 · Cited by 485
Self-citationActivation of the cell death program by inhibition of proteasome function
Drexler, H. C. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.3.855 · Cited by 485
Shibata, T., Kokubu, A., Gotoh, M., Ojima, H., Ohta, T., Yamamoto, M. P., & Hirohashi, S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.06.082 · Cited by 476
A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo
Levis, M. J., Allebach, J., Tse, K.-F., Zheng, R., Baldwin, B. R., Smith, B. D., Jones‐Bolin, S., Ruggeri, B., Dionne, C. A., & Small, D. (2002) · Blood · doi:10.1182/blood.v99.11.3885 · Cited by 472
Shishodia, S., Amin, H. M., Lai, R. L., & Aggarwal, B. B. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.043 · Cited by 468
Self-citationMany actions of cyclooxygenase‐2 in cellular dynamics and in cancer
Cao, Y., & Prescott, S. M. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10068 · Cited by 463
Li, B., & Dou, Q. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070047997 · Cited by 458
AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome
Ruderman, N., & Prentki, M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1344 · Cited by 451
Antineoplastic effects of peroxisome proliferatoractivated receptor γ agonists
Grommes, C., Landreth, G. E., & Heneka, M. T. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01509-8 · Cited by 442
Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines
Mukhopadhyay, A., Bueso-Ramos, C., Chatterjee, D., Pantazis, P., & Aggarwal, B. B. (2001) · Oncogene · doi:10.1038/sj.onc.1204997 · Cited by 442
Self-citationLewis, A. M., Varghese, S., Xu, H., & Alexander, H. R. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-48 · Cited by 442
Combination Treatment With Curcumin and Quercetin of Adenomas in Familial Adenomatous Polyposis
Cruz–Correa, M., Shoskes, D. A., Sanchez, P., Zhao, R., Hylind, L. M., Wexner, S. D., & Giardiello, F. M. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.020 · Cited by 435
Hong, J. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh165 · Cited by 434
Roles of activated Src and Stat3 signaling in melanoma tumor cell growth
Niu, G., Bowman, T., Huang, M., Shivers, S., Reintgen, D., Daud, A., Chang, A., Kraker, A., Jove, R., & Yu, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205859 · Cited by 432
Garcea, G., Jones, D. J. L., Singh, R., Dennison, A. R., Farmer, P. B., Sharma, R. A., Steward, W. P., Gescher, A. J., & Berry, D. P. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601623 · Cited by 426
Shishodia, S., Majumdar, S., Banerjee, S., & Aggarwal, B. B. (2003) · PubMed · Cited by 426
Self-citationNuclear Factor-κB Activation: From Bench to Bedside
Sethi, G., Sung, B., & Aggarwal, B. B. (2008) · Experimental Biology and Medicine · doi:10.3181/0707-mr-196 · Cited by 423
Self-citationHeldin, C., Johnsson, A., Wennergren, S., Wernstedt, C., Betsholtz, C., & Westermark, B. (1986) · Nature · doi:10.1038/319511a0 · Cited by 411
AMP-Activated Protein Kinase as a Drug Target
Hardie, D. G. (2006) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105304 · Cited by 411
Targeting Signal‐Transducer‐and‐Activator‐of‐Transcription‐3 for Prevention and Therapy of Cancer
Aggarwal, B. B., Sethi, G., Ahn, K. S., Sandur, S. K., Pandey, M. K., Kunnumakkara, A. B., Sung, B., & Ichikawa, H. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1378.063 · Cited by 408
Self-citationStattin, P. E. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.23.1910 · Cited by 406
Kanai, M., Yoshimura, K., Asada, M., Imaizumi, A., Suzuki, C., Matsumoto, S., Nishimura, T., Mori, Y., Masui, T., Kawaguchi, Y., et al. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1470-2 · Cited by 402
Self-citationIL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade
Ogata, A., Chauhan, D., Teoh, G. K. H., Treon, S. P., Urashima, M., Schlossman, R. L., & Anderson, K. C. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.5.2212 · Cited by 399
Bayet‐Robert, M., Kwiatowski, F., Leheurteur, M., Gachon, F., Planchat, E., Abrial, C., Mouret‐Reynier, M., Durando, X., Barthomeuf, C., & Chollet, P. J. M. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.1.10392 · Cited by 399
Mori, A., Lehmann, S., O’Kelly, J., Kumagai, T., Desmond, J. C., Pervan, M., McBride, W. H., Kizaki, M., & Koeffler, H. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-0087 · Cited by 399
Mechanism of antiinflammatory actions of curcumine and boswellic acids
Ammon, H. P. T., Safayhi, H., Mack, T., & Sabieraj, J. (1993) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(93)90005-p · Cited by 392
AMPK As a Metabolic Tumor Suppressor: Control of Metabolism and Cell Growth
Luo, Z., Zang, M., & Guo, W. (2010) · Future Oncology · doi:10.2217/fon.09.174 · Cited by 392
Dong, Z., Birrer, M. J., Watts, R. G., Matrisian, L. M., & Colburn, N. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.609 · Cited by 386
The role of the ubiquitin-proteasome pathway in apoptosis
Orlowski, R. Z. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400505 · Cited by 385
A Wnt Survival Guide: From Flies to Human Disease
Chien, A. J., Conrad, W. H., & Moon, R. T. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.445 · Cited by 382
O’Shaughnessy, J., Kelloff, G. J., Gordon, G., Dannenberg, A. J., Hong, W. K., Fabian, C. J., Sigman, C. C., Bertagnolli, M. M., Stratton, S. P., Lam, S. C., et al. (2002) · PubMed · Cited by 381
Xu, C., Huang, M., Shen, G., Yuan, X., Lin, W., Khor, T. O., Conney, A. H., & Kong, A. T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0300 · Cited by 379
Altiok, S., Xu, M. J., & Spiegelman, B. M. (1997) · Genes & Development · doi:10.1101/gad.11.15.1987 · Cited by 378
Iida, K., Itoh, K., Kumagai, Y., Oyasu, R., Hattori, K., Kawai, K., Shimazui, T., Akaza, H., & Yamamoto, M. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1906 · Cited by 372
Epigenetic changes induced by curcumin and other natural compounds
Reuter, S., Gupta, S. C., Park, B., Goel, A., & Aggarwal, B. B. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0222-1 · Cited by 370
Self-citationThe role of Stat5a and Stat5b in signaling by IL-2 family cytokines
Lin, J., & Leonard, W. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203523 · Cited by 369
Nioi, P., & Hayes, J. D. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.05.023 · Cited by 364
Jaiswal, A. S., Marlow, B. P., Gupta, N., & Narayan, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205947 · Cited by 362
Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half, E., Tang, X., Gwyn, K. M., Şahin, A. A., Wathen, K., & Sinicrope, F. A. (2002) · PubMed · Cited by 352
Why is cancer drug discovery so difficult?
Kamb, A., Wee, S., & Lengauer, C. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2155 · Cited by 351
P hosphoinositide 3-K inase : Diverse Roles in Immune Cell Activation
Deane, J. A., & Fruman, D. A. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104721 · Cited by 347
Bedi, A., Barber, J. P., Bedi, G., El‐Deiry, W. S., Sidransky, D., Vala, M., Akhtar, A., Hilton, J., & Jones, R. (1995) · Blood · doi:10.1182/blood.v86.3.1148.1148 · Cited by 345
Inhibition of Prostaglandin and Leukotriene Biosynthesis by Gingerols and Diarylheptanoids.
Kiuchi, F., IWAKAMI, S., Shibuya, M., Hanaoka, F., & Sankawa, U. (1992) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.40.387 · Cited by 345
Disrupting insulin-like growth factor signaling as a potential cancer therapy
Sachdev, D., & Yee, D. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0080 · Cited by 341
Activation of the hedgehog-signaling pathway in human cancer and the clinical implications
Yang, L., Xie, G., Fan, Q., & Xie, J. (2009) · Oncogene · doi:10.1038/onc.2009.392 · Cited by 337
Roles of the Akt/mTOR/p70S6K and ERK1/2 Signaling Pathways in Curcumin-Induced Autophagy
Shinojima, N., Yokoyama, T., Kondo, Y., & Kondo, S. (2007) · Autophagy · doi:10.4161/auto.4916 · Cited by 331
Lo, H., & Hung, M.-C. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602941 · Cited by 324
Sethi, G., Ahn, K. S., & Aggarwal, B. B. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2088 · Cited by 322
Self-citationBharti, A. C., Shishodia, S., Reuben, J. M., Weber, D., Alexanian, R., Vadhan‐Raj, S., Estrov, Z. E., Talpaz, M., & Aggarwal, B. B. (2003) · Blood · doi:10.1182/blood-2003-06-2151 · Cited by 321
Self-citationDisrupting Insulin-Like Growth Factor Signaling as a Potential Cancer Therapy
Sachdev, D., & Yee, D. (2008) · AACR Education book · doi:10.1158/aacr.edb-mct-06-0080 · Cited by 315
Chehl, N., Chipitsyna, G. I., Gong, Q., Yeo, C. J., & Arafat, H. A. (2009) · HPB · doi:10.1111/j.1477-2574.2009.00059.x · Cited by 315
Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer
Khor, T. O., Huang, M.-T., Prawan, A., Liu, Y., Hao, X., Yu, S., Cheung, W. K. L., Chan, J. Y., Reddy, B. S., Yang, C. S., et al. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0028 · Cited by 306
Inhibition of tumor necrosis factor by curcumin, a phytochemical
Chan, M. M.-Y. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00171-u · Cited by 304
Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust
Aoki, Y., Sato, H., Nishimura, N., Takahashi, S., Itoh, K., & Yamamoto, M. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9176 · Cited by 297
Turmeric and Curcumin as Topical Agents in Cancer Therapy
Kuttan, R., Sudheeran, P. C., & Josph, C. D. (1987) · Tumori Journal · doi:10.1177/030089168707300105 · Cited by 293
[6]-Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo
Kim, E.-C., Min, J., Kim, T., Lee, S., Yang, H.-O., Han, S., Kim, Y., & Kwon, Y. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.076 · Cited by 290
Zhang, F., Altorki, N. K., MESTRE, J. R., Subbaramaiah, K., & Dannenberg, A. J. (1999) · Carcinogenesis · doi:10.1093/carcin/20.3.445 · Cited by 287
Pajusola, K., Aprelikova, O. N., Korhonen, J., Kaipainen, A., Pertovaara, L., Alitalo, R., & Alitalo, K. K. (1992) · PubMed · Cited by 285
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
Epelbaum, R., Schaffer, M., Vizel, B., Badmaev, V., & Bar‐Sela, G. (2010) · Nutrition and Cancer · doi:10.1080/01635581.2010.513802 · Cited by 282
Li, M., Zhang, Z., Hill, D. L., Wang, H., & Zhang, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3066 · Cited by 278
The Nuclear Receptor Superfamily: A Rosetta Stone for Physiology
Evans, R. M. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0046 · Cited by 270
Saijo, Y., Tanaka, M., Miki, M., Usui, K., Suzuki, T., Maemondo, M., Hong, X., Tazawa, R., Kikuchi, T., Matsushima, K., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.469 · Cited by 249
Pandey, M. K., Sung, B., Ahn, K. S., Kunnumakkara, A. B., Chaturvedi, M. M., & Aggarwal, B. B. (2007) · Blood · doi:10.1182/blood-2007-03-079616 · Cited by 247
Self-citationCurcumin Inhibits the Proteasome Activity in Human Colon Cancer Cells In vitro and In vivo
Milacic, V., Banerjee, S., Landis‐Piwowar, K. R., Sarkar, F. H., Majumdar, A. P. N., & Dou, Q. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6246 · Cited by 243
Khuri, F. R., Lee, J. J., Lippman, S. M., Kim, E. S., Cooper, J. S., Benner, S. E., Winn, R. J., Pajak, T. F., Williams, B., Shenouda, G., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj091 · Cited by 239
Pathak, A., Bhutani, M., Nair, S. A., Ahn, K. S., Chakraborty, A., Kadara, H. N., Guha, S., Sethi, G., & Aggarwal, B. B. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0348 · Cited by 238
Self-citationYi, T., Yi, Z., Cho, S., Luo, J., Pandey, M. K., Aggarwal, B. B., & Liu, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5944 · Cited by 237
Self-citationDarnay, B. G., Singh, S., Chaturvedi, M. M., & Aggarwal, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.14867 · Cited by 232
Self-citationKim, S. S., Oh, O.-J., Min, H., Park, E., Kim, Y., Park, H. J., Han, Y. N., & Lee, S. K. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00288-1 · Cited by 232
Sato, H., Ishihara, S., Kawashima, K., Moriyama, N., Suetsugu, H., Kazumori, H., Okuyama, T., Rumi, M. A. K., Fukuda, R., Nagasue, N., et al. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1457 · Cited by 225
Suppression of oncogene-induced transformation by a deletion mutant of c-jun.
Brown, P. H., Alani, R. M., Preis, L. H., Szabo, E. M., & Birrer, M. J. (1993) · PubMed · Cited by 224
Target selection in drug discovery
Knowles, J., & Gromo, G. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd986 · Cited by 216
Chainy, G. B., Manna, S. K., Chaturvedi, M. M., & Aggarwal, B. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203614 · Cited by 215
Self-citationBarleon, B., Siemeister, G., Martiny‐Baron, G., Weindel, K., Herzog, C., & Marmé, D. (1997) · PubMed · Cited by 214
Chili Pepper Consumption and Gastric Cancer in Mexico: A Case-Control Study
López-Carnllo, L., Hernández‐Ávila, M., & Dubrow, R. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116993 · Cited by 214
Capsaicin in hot chili pepper: Carcinogen, co-carcinogen or anticarcinogen?
Surh, Y., & Lee, S.-J. (1996) · Food and Chemical Toxicology · doi:10.1016/0278-6915(95)00108-5 · Cited by 212
Damage to the Gastric Mucosa: Effects of Salicylates and Stimulation
Davenport, H. W., Cohen, B. J., Bree, M. M., & Davenport, V. D. (1965) · Gastroenterology · doi:10.1016/s0016-5085(19)34565-2 · Cited by 209
Curcumin Disrupts the Mammalian Target of Rapamycin-Raptor Complex
Beevers, C. S., Chen, L., Liu, L., Luo, Y., Webster, N. J. G., & Huang, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2367 · Cited by 208
AP1/ jun Function Is Differentially Induced in Promotion-Sensitive and Resistant JB6 Cells
Bernstein, L. R., & Colburn, N. H. (1989) · Science · doi:10.1126/science.2541502 · Cited by 207
Li, F., Fernandez, P. P., Rajendran, P., Hui, K. M., & Sethi, G. (2010) · Cancer Letters · doi:10.1016/j.canlet.2009.12.003 · Cited by 207
PIK3CA mutations in breast cancer are associated with poor outcome
Li, S. Y., Rong, M., Grieu, F., & Iacopetta, B. J. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9048-0 · Cited by 206
Thoennissen, N. H., O’Kelly, J., Lu, D., Iwanski, G. B., La, D. T., Abbassi, S., Leiter, A., Karlan, B. Y., Mehta, R. G., & Koeffler, H. P. (2009) · Oncogene · doi:10.1038/onc.2009.335 · Cited by 204
Lee, Y. K., Lee, W. S., Hwang, J. T., Kwon, D. Y., Surh, Y. J., & Park, O. J. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf802737z · Cited by 204
Aggarwal, B. B., Kuiken, M. E. V., Iyer, L. H., Harikumar, K. B., & Sung, B. (2009) · Experimental Biology and Medicine · doi:10.3181/0902-mr-78 · Cited by 204
Self-citationTakada, Y., Murakami, A., & Aggarwal, B. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208845 · Cited by 199
Self-citationLee, I., Lim, J., Gal, J., Kang, J. C., Kim, H. J., Kang, B. Y., & Choi, H. J. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.11.008 · Cited by 198
Effects of thymoquinone (volatile oil of black cumin) on rheumatoid arthritis in rat models
Tekeoğlu, İ., Dogan, A., Ediz, L., Budancamanak, M., & Demirel, A. (2007) · Phytotherapy Research · doi:10.1002/ptr.2143 · Cited by 198
Han, S., Keum, Y., Seo, H., & Surh, Y. (2002) · BMB Reports · doi:10.5483/bmbrep.2002.35.3.337 · Cited by 198
Capsaicin Is a Novel Blocker of Constitutive and Interleukin-6–Inducible STAT3 Activation
Bhutani, M., Pathak, A., Nair, S. A., Kunnumakkara, A. B., Guha, S., Sethi, G., & Aggarwal, B. B. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2575 · Cited by 197
Self-citationSquires, M. S., Hudson, E. A., Howells, L. M., Sale, S., Houghton, C. E., Jones, J. L., Fox, L. H., Dickens, M., Prigent, S. A., & Manson, M. M. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01517-4 · Cited by 194
Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2.
Sánchez-Garcı́a, I., & Grütz, G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5287 · Cited by 193
Yu, S., Shen, G., Khor, T. O., Kim, J. H., & Kong, A. T. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2400 · Cited by 192
Sites of alkylation of human Keap1 by natural chemoprevention agents
Luo, Y., Eggler, A. L., Liu, D., Liu, G., Mesecar, A. D., & van Breemen, R. B. (2007) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2007.09.015 · Cited by 191
Kundu, N., & Fulton, A. M. (2002) · PubMed · Cited by 190
Israf, D. A., Khaizurin, T., SYAHIDA, A., Lajis, N. H., & Khozirah, S. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.04.025 · Cited by 190
Kang, J., Kim, C.-S., Han, I., Kawada, T., & Yu, R. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.07.082 · Cited by 188
Rai, B., Kaur, J., Jacobs, R., & Singh, J. (2010) · Journal of Oral Science · doi:10.2334/josnusd.52.251 · Cited by 186
Models for prevention and treatment of cancer: Problems vs promises
Aggarwal, B. B., Danda, D., Gupta, S. R., & Gehlot, P. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.027 · Cited by 184
Self-citationCurcumin induces apoptosis via inhibition of PI3′-kinase/AKT pathway in Acute T cell Leukemias
Hussain, A. R., Al-Rasheed, M. M., Manogaran, P. S., Al‐Hussein, K. A., Platanias, L. C., Al-Kuraya, K. S., & Shahab Uddin, M. S. (2006) · APOPTOSIS · doi:10.1007/s10495-006-3392-3 · Cited by 184
Ide, H., Tokiwa, S., Sakamaki, K., Nishio, K., Isotani, S., Muto, S., Hama, T., Masuda, H., & Horie, S. (2010) · The Prostate · doi:10.1002/pros.21147 · Cited by 182
Shishodia, S., & Aggarwal, B. B. (2005) · Oncogene · doi:10.1038/sj.onc.1209194 · Cited by 179
Self-citationLi, F., Rajendran, P., & Sethi, G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00874.x · Cited by 176
Li, H., Ahonen, T. J., Alanen, K. A., Xie, J., LeBaron, M. J., Pretlow, T. G., Ealley, E. L., Zhang, Y., Nurmi, M. J., Singh, B., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3499 · Cited by 176
Ara, T., Song, L., Shimada, H., Keshelava, N., Russell, H. V., Metelitsa, L. S., Groshen, S. G., Seeger, R. C., & DeClerck, Y. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-0613 · Cited by 175
Arlt, A., Vorndamm, J., Müerköster, S. S., Yu, H., Schmidt, W. E., Fölsch, U. R., & Schäfer, H. (2002) · PubMed · Cited by 173
G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2.
DuBois, R. N., Shao, J., Tsujii, M., Sheng, H., & Beauchamp, R. D. (1996) · PubMed · Cited by 172
Harikumar, K. B., Kunnumakkara, A. B., Ahn, K. S., Anand, P., Krishnan, S., Guha, S., & Aggarwal, B. B. (2008) · Blood · doi:10.1182/blood-2008-04-151944 · Cited by 171
Self-citationThe mTOR Pathway: A New Target in Cancer Therapy
Ciuffreda, L., Sanza, C. D., Incani, U. C., & Milella, M. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910791517172 · Cited by 171
Ellison, N. M., Loprinzi, C. L., Kugler, J., Hatfield, A. K., Miser, A. W., Sloan, J. A., Wender, D. B., Rowland, K. M., Molina, R., Cascino, T. L., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.8.2974 · Cited by 169
Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting
Zick, S. M., Ruffin, M. T., Lee, J. J., Normolle, D. P., Siden, R., AlRawi, S. N., & Brenner, D. E. (2008) · Supportive Care in Cancer · doi:10.1007/s00520-008-0528-8 · Cited by 168
Promising molecular targets for cancer prevention: AP-1, NF-κB and Pdcd4
Young, M. R., Yang, H., & Colburn, N. H. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)00009-6 · Cited by 167
Pillai, A. K., Sharma, K. K., Gupta, Y. K., & Bakhshi, S. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22778 · Cited by 165
James, M. A., Lee, J. H., & Klingelhutz, A. (2006) · Journal of Virology · doi:10.1128/jvi.01942-05 · Cited by 162
Prasad, C. P., Rath, G., Mathur, S. R., Bhatnagar, D., & Ralhan, R. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2009.06.012 · Cited by 161
Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu.
Hong, R. L., Spohn, W. H., & Hung, M. (1999) · PubMed · Cited by 161
Kaur, G., Athar, M., & Alam, M. S. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20601 · Cited by 159
Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling.
Johnson, S. M., Gulhati, P., Arrieta, I., Wang, X., Uchida, T., Gao, T., & Evers, B. M. (2009) · PubMed · Cited by 157
Chen, A., & Xu, J. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00209.2004 · Cited by 157
Lev‐Ari, S., Starr, A., Vexler, A. M., Karaush, V., Loew, V., Greif, J., Fenig, E., Aderka, D., & Ben‐Yosef, R. (2006) · PubMed · Cited by 152
Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke
Ye, Y. N. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi012 · Cited by 150
Flagged first, then by citations
Research works printed but not linked: 37
- Shishodia S, 2003, Cancer Res, 63, 4375
- Buettner R, 2002, Clin Cancer Res, 8, 945
- Brown P H, 1993, Oncogene, 8, 877
- O’Shaughnessy J A, 2002, Clin Cancer Res, 8, 314
- Choi Y H, 2000, Int J Oncol, 17, 565
- Lev-Ari S, 2006, Anticancer Res, 26, 4423
- Molina M A, 2001, Cancer Res, 61, 4744
- Hong R L, 1999, Clin Cancer Res, 5, 1884
- Pajusola K, 1992, Cancer Res, 52, 5738
- Barleon B, 1997, Cancer Res, 57, 5421
- Zhao Z D, 2009, Zhong Yao Cai, 32, 732
- Chen L X, 2011, Cancer Biol Ther, 11
- Pan W, 2008, Oncol Rep, 20, 1553
- Wu L X, 2003, Acta Pharmacol Sin, 24, 1155
- Clark C A, 2010, Cancer Prev Res (Phila)
- Johnson S M, 2009, Anticancer Res, 29, 3185
- Deeb D, 2010, Anticancer Res, 30, 3333
- Surh Y J, 1999, J Environ Pathol Toxicol Oncol, 18, 131
- Arlt A, 2002, Cancer Res, 62, 910
- Xu Y X, 1997, Exp Hematol, 25, 413
- DuBois R N, 1996, Cancer Res, 56, 733
- Takeda H, 2003, Cancer Res, 63, 4872
- Einspahr J G, 2003, Cancer Res, 63, 3891
- Half E, 2002, Cancer Res, 62, 1676
- Kundu N, 2002, Cancer Res, 62, 2343
- Wolff H, 1998, Cancer Res, 58, 4997
- Huang M T, 1991, Cancer Res, 51, 813
- Lee Y S, 2002, J Environ Pathol Toxicol Oncol, 21, 113
- Faronato M, 2007, Histol Histopathol, 22, 1109
- Lepage C, 2010, Int J Oncol, 36, 1183
- Lust S, 2009, Anticancer Res, 29, 3797
- Waddington C H, 1942, Endeavour, 1, 18
- Reuter S, 2011, Genes Nutr
- Sharma R A, 2001, Clin Cancer Res, 7, 1894
- Cheng A L, 2001, Anticancer Res, 21, 2895
- Ireson C, 2001, Cancer Res, 61, 1058
- Futrell J M, 1993, Cutis, 52, 288
Cited by
Sorted by citations
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
Kunnumakkara, A. B., Bordoloi, D., Padmavathi, G., Monisha, J., Roy, N. K., Prasad, S., & Aggarwal, B. B. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13621 · Cited by 1,068
Self-citationThe role and place of medicinal plants in the strategies for disease prevention
Sofowora, A., Ogunbodede, E. O., & Onayade, A. A. (2013) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.4314/ajtcam.v10i5.2 · Cited by 1,047
Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
Siveen, K. S., Sikka, S., Surana, R., Dai, X., Zhang, J., Kumar, A. P., Tan, B. K. H., Sethi, G., & Bishayee, A. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.12.005 · Cited by 645
Curcumin, Inflammation, and Chronic Diseases: How Are They Linked?
He, Y., Yue, Y., Zheng, X., Zhang, K., Chen, S., & Du, Z. (2015) · Molecules · doi:10.3390/molecules20059183 · Cited by 632
Pulido‐Moran, M., Moreno‐Fernández, J., Ramírez-Tortosa, C. L., & Ramírez-Tortosa, M. C. (2016) · Molecules · doi:10.3390/molecules21030264 · Cited by 571
Metadata
- Authors
- Sung, B., Prasad, S., Yadav, V. R., & Aggarwal, B. B.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Venue
- Nutrition and Cancer
- Publisher
- Informa UK Limited
- Published
- 2012-02
- Volume
- 64
- Issue
- 2
- Pages
- 173-197
- ISSN
- 0163-5581 (ISSN-L)
- 1532-7914
- PMC
- PMC3645308
- OpenAlex
- W2035997417
- Cited by
- 204
- References
- 324
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 11 · 2023: 10 · 2022: 18 · 2021: 28 · 2020: 11 · 2019: 17 · 2018: 9 · 2017: 15 · 2016: 18 · 2015: 14 · 2014: 13 · 2013: 20 · 2012: 7
- FWCI
- 1.31
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Nutrition and Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA-16672, P01CA124787, CA-124787-01A2, P30CA016672)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Medicinal Plant Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Curcumin's Biomedical Applications
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Bioactive natural compounds
- Keywords
- anticancer agents, curcumin, gingerol, xanthohumol, eugenol, thymoquinone, capsaicin, anethole, cardamonin, gambogic acid, ursolic acid, dibenzoylmethane, diosgenin, Nigella sativa, licorice, turmeric, Syzygium aromaticum, black cardamom, galangal, red chili, Rosmarinus officinalis, Humulus lupulus, fenugreek, kokum, transcription factors, protein kinases, growth factors, inflammatory mediators, cancer prevention
- MeSH terms
- Animals, Antineoplastic Agents, Phytogenic, Humans, Phytotherapy, Neoplasms, Protein Kinases, Transcription Factors, Signal Transduction, NF-kappa B, Spices, Receptors, Growth Factor, Inflammation Mediators, Dietary Supplements, Intercellular Signaling Peptides and Proteins, Cell Line, Tumor, Protein Kinase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review